Plancorp LLC Buys 1,161 Shares of Intuitive Surgical, Inc. $ISRG

Plancorp LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,161 shares of the medical equipment provider’s stock, valued at approximately $502,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Bank of America Corp DE raised its holdings in Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in Intuitive Surgical during the 2nd quarter valued at about $1,335,753,000. Amundi boosted its stake in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Intuitive Surgical by 10.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after purchasing an additional 184,044 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, Director Craig Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $510,370.00. Following the sale, the director owned 1,150 shares of the company’s stock, valued at approximately $510,370. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the sale, the vice president owned 1,026 shares in the company, valued at $464,993.46. The trade was a 79.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 49,128 shares of company stock worth $21,614,167 over the last three months. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $452.80 on Monday. The firm has a market cap of $156.96 billion, a PE ratio of 54.75, a PEG ratio of 3.12 and a beta of 1.45. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a fifty day moving average price of $409.93 and a 200 day moving average price of $431.89.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter last year, the firm earned $2.40 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ISRG. KeyCorp reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Truist Financial dropped their price objective on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. HSBC cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price on the stock. in a report on Thursday, July 30th. TD Cowen reiterated a “buy” rating and issued a $485.00 price target on shares of Intuitive Surgical in a research report on Monday, October 19th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Company Profile